Jump to navigation
The latest clinical and political news for Australian Neurologists
Head injury and loss of taste; Alzheimer biomarkers; Stroke research grants
Patients without Lyme can have similar symptoms, research shows.
But higher level evidence is needed, researchers say.
Changing the health service will be a challenge, he says.
Blood test reveals brain amyloid beta levels.
A spike in infections killed six people last year.
Memory, executive function vulnerable, research shows.
Neurologists say driving restrictions need to be implemented.
It took 72 hours for Vanessa Potter to lose her sight.
A drug used for rheumatoid arthritis seems to bring benefits
Almost a third of rural patients at risk of stroke are not getting anticoagulant therapy.
Australian specialist says 2017 was a watershed year
Not surprisingly, several companies have left this territory in recent years.
Launch of Australia's first clinical guidelines on diagnosis and management of paediatric stroke.
Clare Pain catches a glimpse of the raw material of neurological research.
US neurologists say the Brave Dreams trial shows venoplasty is useless.
Sub-groups formerly considered at risk can get standard treatment.
The author requested the retractions.
While survival rates for most cancers continue to improve in Australia, brain cancers aren’t seeing the same success...
The case of a patient who was interested in a quick fix.
Australian Doctor Group (ADG) is Australia’s premier business to business publisher, delivering the country’s most recognised industry magazines and websites.
Ensure you never miss a big story by signing up for our daily e-newsletter.